BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2982405)

  • 1. The effect of 2'-fluoro-2'-deoxycytidine on herpes virus growth.
    Wohlrab F; Jamieson AT; Hay J; Mengel R; Guschlbauer W
    Biochim Biophys Acta; 1985 Mar; 824(3):233-42. PubMed ID: 2982405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbocyclic analogues of 5-halocytosine nucleosides.
    Shealy YF; O'Dell CA; Arnett G; Shannon WM; Thorpe MC; Riordan JM; Coburn WC
    J Med Chem; 1986 Sep; 29(9):1720-5. PubMed ID: 3018246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro.
    Aswell JF; Allen GP; Jamieson AT; Campbell DE; Gentry GA
    Antimicrob Agents Chemother; 1977 Aug; 12(2):243-54. PubMed ID: 197886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.
    Lopez C; Watanabe KA; Fox JJ
    Antimicrob Agents Chemother; 1980 May; 17(5):803-6. PubMed ID: 6249196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of 5-substituted analogs of deoxycytidine into DNA of herpes simplex virus-infected or - transformed cells without deamination to the thymidine analog.
    Fox L; Dobersen MJ; Greer S
    Antimicrob Agents Chemother; 1983 Mar; 23(3):465-76. PubMed ID: 6303214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.
    Jamieson AT; Gentry GA; Subak-Sharpe JH
    J Gen Virol; 1974 Sep; 24(3):465-80. PubMed ID: 4372299
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
    Balzarini J; De Clercq E
    Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of 9-(2-hydroxyethoxymethyl) guanine against equine herpesvirus type 1 HH-1 strain and pseudorabies virus YS-81 strain.
    Sakamoto K
    Nihon Juigaku Zasshi; 1990 Oct; 52(5):1109-11. PubMed ID: 2177802
    [No Abstract]   [Full Text] [Related]  

  • 10. The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    De Clercq E
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():85-95. PubMed ID: 6092320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
    De Clercq E; Bères J; Bentrude WG
    Mol Pharmacol; 1987 Aug; 32(1):286-92. PubMed ID: 3039343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial and herpesvirus-specific deoxypyrimidine kinases.
    Leung WC; Dubbs DR; Trkula D; Kit S
    J Virol; 1975 Sep; 16(3):486-97. PubMed ID: 169387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The synergistic antiviral effect of acyclovir and ribavirin against the herpes simplex type-1 virus and the pseudorabies virus in vitro].
    Shishkov S; Pancheva S
    Acta Microbiol Bulg; 1990; 25():69-75. PubMed ID: 2166426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
    Honess RW; O'Hare P; Young D
    J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 1-beta-D-arabinofuranosylthymine on the growth of herpes simplex virus types 1 and 2.
    Falke D; Moser H; Link D; Müller WE
    J Gen Virol; 1979 Feb; 42(2):435-8. PubMed ID: 217968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.
    De Clercq E; Descamps J; Verhelst G; Walker RT; Jones AS; Torrence PF; Shugar D
    J Infect Dis; 1980 May; 141(5):563-74. PubMed ID: 6246180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
    Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
    Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of viruses to phosphorylated 9-(2-hydroxyethoxymethyl)guanine revealed in TK-transformed cells.
    Darby G; Larder BA; Bastow KF; Field HJ
    J Gen Virol; 1980 Jun; 48(Pt 2):451-4. PubMed ID: 6249891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cytosine arabinoside on the incorporation of pyrimidine nucleosides into hamster cells transformed by herpes simplex type 1 and type 2 viruses and by human cytomegalovirus.
    Roubal J; Závada V; Vejsada J; Boldogh I; Vonka V
    Acta Virol; 1979 Jul; 23(4):314-8. PubMed ID: 40418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of three 2'-fluoropyrimidine nucleosides and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (BW B759U) against pseudorabies and equine rhinopneumonitis virus infection in vitro and in laboratory animals.
    Rollinson EA
    Antiviral Res; 1987 Jan; 7(1):25-33. PubMed ID: 3026244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.